Professore straordinario a tempo determinato
Settore scientifico disciplinare: 


  • Crippa, M., Bersini, S., Gilardi, M., Arrigoni, C., Gamba, S., Falanga, A., et al. (2021). A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation. LAB ON A CHIP, 21(6 (21 March 2021)), 1061-1072 [10.1039/d0lc01011a]. Dettaglio
  • Costanzo, S., Parisi, R., De Curtis, A., Gamba, S., Russo, L., Persichillo, M., et al. (2021). Tissue Plasminogen Activator Levels and Risk of Breast Cancer in a Case-Cohort Study on Italian Women: Results from the Moli-sani Study. THROMBOSIS AND HAEMOSTASIS, 121(4), 449-456 [10.1055/s-0040-1718531]. Dettaglio
  • Pengo, V., Hoxha, A., Andreoli, L., Tincani, A., Silvestri, E., Prisco, D., et al. (2021). Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 19(2), 531-535 [10.1111/jth.15158]. Dettaglio
  • Giaccherini, C., Marchetti, M., Masci, G., Verzeroli, C., Russo, L., Celio, L., et al. (2020). Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer. HAEMATOLOGICA, 105(6), 1704-1711. Dettaglio
  • Palareti, G., Legnani, C., Antonucci, E., Cosmi, B., Poli, D., Testa, S., et al. (2020). D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study. INTERNAL AND EMERGENCY MEDICINE, 15(3), 453-462 [10.1007/s11739-019-02216-y]. Dettaglio